https://allsci.com/news/clinical-trials/atg-022-phase-iii-trial-gastric-cancer-antengene/ AllScien 2026-09-21T11:06:39.476952Z Antengene launches pivotal Phase III trial of ATG-022 in third-line gastric cancer https://allsci.com/news/clinical-trials/lavengratinib-achondroplasia-trial-abbiskos/ AllScien 2026-09-21T10:29:22.663060Z Abbisko's lavengratinib achieves 100% responder rate in early achondroplasia trial https://allsci.com/news/telix-itm-acquisition-radioisotope-acquires/ AllScien 2026-09-21T10:18:56.167117Z Telix acquires ITM Isotope Technologies for USD 1.65b to secure radioisotope supply chain https://allsci.com/news/regulatory-policy/pharma-licensing-deals-china-us-treasury-drafts/ AllScien 2026-09-21T10:06:32.472403Z US Treasury reportedly drafting rules to preserve pharma licensing deals with China https://allsci.com/news/licensing-and-partnerships/novo-nordisk-obesity-acquisition-acquires-three/ AllScien 2026-09-21T08:53:37.077928Z Novo acquires three early-stage obesity programs from Columbia-linked Kallyope